This echoes a recent study’s positive association between visfatin and carbohydrate intake, acknowledging limitations like small sample size, younger participants, shorter diabetes duration, and the lack of adjustments for cardiovascular drug usage [23]. The gene discussed is NAMPT; the disease is diabetes mellitus.